Cystic fibrosis-related diabetes testing in San Giovanni al Natisone
Find health labs to test for Cystic fibrosis-related diabetes in San Giovanni al Natisone and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by CORMEDICA SRL
Via Filanda 2, 34071 Cormons Gorizia, Italy
3.6 km
Diabetes Test by Policlinico Città di Udine - Polo 2
Viale Venezia, 410, 33100 Udine UD, Italia
9.9 km
Diabetes Test by Casa di Cura Salus
Corso Giuseppe Verdi, 12, 34170 Gorizia GO, Italia
10.8 km
Unverified
A Diabetes Test costs €33.00
See Details
Diabetes Test by Friuli Coram
Via Teobaldo Ciconi, 10, 34170 Gorizia GO, Italia
10.8 km
Hemoglobin Test by Polismedica
Via Rosa 18, 33078 San Vito al Tagliamento Pordenone, Italy
26.8 km
Diabetes Test by Synlab
Campo Guglielmo Marconi, 24, 30015 Chioggia VE, Italia
75.6 km
Hemoglobin Test by Synlab
Via Antonio Zanchi, 89, 35133 Padova PD, Italia
83.7 km
Hemoglobin Test by Synlab
Via Giovanni Boccaccio, 106, 35128 Padova PD, Italia
83.7 km
Hemoglobin Test by Synlab Euganea Medica
Via Cristoforo Colombo, 13, 35020 Albignasego PD, Italia
86.1 km
Diabetes Test by Laboratorio Analisi Cliniche Girlando e Paravizzini
Viale Giuseppe Di Vittorio, 10, 45018 Porto Tolle RO, Italia
87.9 km
Unverified
A Diabetes Test costs €50.00
See Details
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
